Company News 

Consort Medical enters addiction treatment market

Consort Medical enters addiction treatment market

Consort Medical (CSRT) has entered a partnership with Opiant Pharmaceuticals, marking the second time it has signed a deal that uses the expertise of both its drug and device divisions. More significantly it is the group’s first dose of the opioid addiction market, where growth has accelerated amid the tragic increase in drug dependency in the US.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now